Martin Muddu1,2, Andrew K Tusubira2, Srish K Sharma3, Ann R Akiteng2, Isaac Ssinabulya1,2,4, Jeremy I Schwartz2,5. 1. Department of Medicine, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda. 2. Uganda Initiative for Integrated Management of Non-Communicable Diseases (UINCD), Kampala, Uganda. 3. Wake Forest School of Medicine, Winston-Salem, NC. 4. Uganda Heart Institute, Mulago Hospital Complex, Kampala, Uganda. 5. Section of General Internal Medicine, Yale School of Medicine, CT.
Abstract
BACKGROUND: Persons living with HIV (PLHIV) are at increased risk of cardiovascular disease. Integration of services for hypertension (HTN), the primary cardiovascular disease risk factor, into HIV care programs is recommended in Uganda, though, uptake has been limited. We sought to compare the care cascades for HTN and HIV within an HIV program in Eastern Uganda. METHODS: We conducted a retrospective cohort study of all PLHIV enrolled in 3 HIV clinics between 2014 and 2017. We determined the proportion of patients in the following cascade steps over 12 months: Screened, Diagnosed, Initiated on treatment, Retained, Monitored, and Controlled. Cascades were analyzed using descriptive statistics and compared using χ and t tests. RESULTS: Of 1649 enrolled patients, 98.5% were initiated on HIV treatment, of whom 70.7% were retained in care, 100% had viral load monitoring, and 90.3% achieved control (viral suppression). Four hundred fifty-six (27.7%) participants were screened for HTN, of whom 46.9% were diagnosed, 88.1% were initiated on treatment, 57.3% were retained in care, 82.7% were monitored, and 24.3% achieved blood pressure control. There were no differences in any HIV cascade step between participants with HIV alone and those with both conditions. CONCLUSIONS: The HIV care cascade approached global targets, whereas the parallel HTN care cascade demonstrated notable quality gaps. Management of HTN within this cohort did not negatively impact HIV care. Our findings suggest that models of integration should focus on screening PLHIV for HTN and retention and control of those diagnosed to fully leverage the successes of HIV programs.
BACKGROUND:Persons living with HIV (PLHIV) are at increased risk of cardiovascular disease. Integration of services for hypertension (HTN), the primary cardiovascular disease risk factor, into HIV care programs is recommended in Uganda, though, uptake has been limited. We sought to compare the care cascades for HTN and HIV within an HIV program in Eastern Uganda. METHODS: We conducted a retrospective cohort study of all PLHIV enrolled in 3 HIV clinics between 2014 and 2017. We determined the proportion of patients in the following cascade steps over 12 months: Screened, Diagnosed, Initiated on treatment, Retained, Monitored, and Controlled. Cascades were analyzed using descriptive statistics and compared using χ and t tests. RESULTS: Of 1649 enrolled patients, 98.5% were initiated on HIV treatment, of whom 70.7% were retained in care, 100% had viral load monitoring, and 90.3% achieved control (viral suppression). Four hundred fifty-six (27.7%) participants were screened for HTN, of whom 46.9% were diagnosed, 88.1% were initiated on treatment, 57.3% were retained in care, 82.7% were monitored, and 24.3% achieved blood pressure control. There were no differences in any HIV cascade step between participants with HIV alone and those with both conditions. CONCLUSIONS: The HIV care cascade approached global targets, whereas the parallel HTN care cascade demonstrated notable quality gaps. Management of HTN within this cohort did not negatively impact HIV care. Our findings suggest that models of integration should focus on screening PLHIV for HTN and retention and control of those diagnosed to fully leverage the successes of HIV programs.
Authors: Alexandra Cameron; Ilse Roubos; Margaret Ewen; Aukje K Mantel-Teeuwisse; Hubertus G M Leufkens; Richard O Laing Journal: Bull World Health Organ Date: 2011-03-14 Impact factor: 9.408
Authors: Bohdan Nosyk; Julio S G Montaner; Guillaume Colley; Viviane D Lima; Keith Chan; Katherine Heath; Benita Yip; Hasina Samji; Mark Gilbert; Rolando Barrios; Réka Gustafson; Robert S Hogg Journal: Lancet Infect Dis Date: 2013-09-27 Impact factor: 25.071
Authors: Ben J Marais; Knut Lönnroth; Stephen D Lawn; Giovanni Battista Migliori; Peter Mwaba; Philippe Glaziou; Matthew Bates; Ruth Colagiuri; Lynn Zijenah; Soumya Swaminathan; Ziad A Memish; Michel Pletschette; Michael Hoelscher; Ibrahim Abubakar; Rumina Hasan; Afia Zafar; Guiseppe Pantaleo; Gill Craig; Peter Kim; Markus Maeurer; Marco Schito; Alimuddin Zumla Journal: Lancet Infect Dis Date: 2013-03-24 Impact factor: 25.071
Authors: Farrah J Mateen; Steve Kanters; Robert Kalyesubula; Barbara Mukasa; Esther Kawuma; Andre P Kengne; Edward J Mills Journal: J Hypertens Date: 2013-07 Impact factor: 4.844
Authors: Michael A Weber; Ernesto L Schiffrin; William B White; Samuel Mann; Lars H Lindholm; John G Kenerson; John M Flack; Barry L Carter; Barry J Materson; C Venkata S Ram; Debbie L Cohen; Jean-Claude Cadet; Roger R Jean-Charles; Sandra Taler; David Kountz; Raymond R Townsend; John Chalmers; Agustin J Ramirez; George L Bakris; Jiguang Wang; Aletta E Schutte; John D Bisognano; Rhian M Touyz; Dominic Sica; Stephen B Harrap Journal: J Clin Hypertens (Greenwich) Date: 2013-12-17 Impact factor: 3.738
Authors: Gabriel Chamie; Dalsone Kwarisiima; Tamara D Clark; Jane Kabami; Vivek Jain; Elvin Geng; Maya L Petersen; Harsha Thirumurthy; Moses R Kamya; Diane V Havlir; Edwin D Charlebois Journal: PLoS One Date: 2012-08-20 Impact factor: 3.240
Authors: Gerald S Bloomfield; Joseph W Hogan; Alfred Keter; Thomas L Holland; Edwin Sang; Sylvester Kimaiyo; Eric J Velazquez Journal: BMC Infect Dis Date: 2014-05-22 Impact factor: 3.090
Authors: Julian T Hertz; Sainikitha Prattipati; Godfrey L Kweka; Jerome J Mlangi; Tumsifu G Tarimo; Blandina T Mmbaga; Nathan M Thielman; Francis M Sakita; Matthew P Rubach; Gerald S Bloomfield; Preeti Manavalan Journal: Glob Public Health Date: 2022-03-13
Authors: Alexander Kintu; David Sando; Samson Okello; Gerald Mutungi; David Guwatudde; Nicolas A Menzies; Goodarz Danaei; Stéphane Verguet Journal: J Int AIDS Soc Date: 2020-06 Impact factor: 5.396
Authors: Martin Muddu; Andrew K Tusubira; Brenda Nakirya; Rita Nalwoga; Fred C Semitala; Ann R Akiteng; Jeremy I Schwartz; Isaac Ssinabulya Journal: Implement Sci Commun Date: 2020-05-04
Authors: Kaku So-Armah; Laura A Benjamin; Gerald S Bloomfield; Matthew J Feinstein; Priscilla Hsue; Benson Njuguna; Matthew S Freiberg Journal: Lancet HIV Date: 2020-04 Impact factor: 16.070
Authors: Emmanuel Peprah; Mari Armstrong-Hough; Stephanie H Cook; Barbara Mukasa; Jacquelyn Y Taylor; Huichun Xu; Linda Chang; Joyce Gyamfi; Nessa Ryan; Temitope Ojo; Anya Snyder; Juliet Iwelunmor; Oliver Ezechi; Conrad Iyegbe; Paul O'Reilly; Andre Pascal Kengne Journal: Int J Environ Res Public Health Date: 2021-03-18 Impact factor: 3.390
Authors: Tessa J M Geraedts; Daniel Boateng; Karel C Lindenbergh; Diede van Delft; Hanna M Mathéron; Gulia L E Mönnink; Janine P J Martens; Daniel van Leerdam; Jonathan Vas Nunes; Sonnia-Magba Bu-Buakei Jabbi; Mohamed S Kpaka; Josien Westendorp; Alex J van Duinen; Osman Sankoh; Martin P Grobusch; Håkon A Bolkan; Kerstin Klipstein-Grobusch Journal: Trop Med Int Health Date: 2021-08-18 Impact factor: 3.918